{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:18Z","timestamp":1791357498819,"version":"4.3.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.schres.2017.04.010","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T00:46:14Z","timestamp":1492476374000},"page":"13-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The relative prevalence of schizophrenia among cannabis and cocaine users attending addiction services"],"prefix":"10.1016","volume":"194","author":[{"given":"Nicol\u00e1s","family":"Libuy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5109-3636","authenticated-orcid":false,"given":"Valeria","family":"de Angel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian P.","family":"Mundt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.schres.2017.04.010_bb0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1081\/ADA-120015873","article-title":"Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence","volume":"28","author":"Agosti","year":"2002","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"7374","key":"10.1016\/j.schres.2017.04.010_bb0010","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","article-title":"Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study","volume":"325","author":"Arseneault","year":"2002","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.schres.2017.04.010_bb0015","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/schbul\/sbu095","article-title":"The impact of cannabis use on clinical outcomes in recent onset psychosis","volume":"41","author":"Barrowclough","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.schres.2017.04.010_bb0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/107385840200800407","article-title":"Dynamics of extracellular dopamine in the acute and chronic actions of cocaine","volume":"8","author":"Bradberry","year":"2002","journal-title":"Neuroscientist"},{"issue":"6","key":"10.1016\/j.schres.2017.04.010_bb0035","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1192\/bjp.bp.109.064220","article-title":"High-potency cannabis and the risk of psychosis","volume":"195","author":"Di Forti","year":"2009","journal-title":"Br J Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2017.04.010_bb0040","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/schbul\/sbt181","article-title":"Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users","volume":"40","author":"Di Forti","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.schres.2017.04.010_bb0045","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in cannabis potency over the last 2 decades (1995\u20132014): analysis of current data in the United States","volume":"79","author":"ElSohly","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.04.010_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122404","article-title":"Social functioning trajectories of young first-episode psychosis patients with and without cannabis misuse: a 30-month follow-up study","volume":"10","author":"Gonz\u00e1lez-Blanch","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.schres.2017.04.010_bb0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/YCO.0b013e32812144cc","article-title":"Prevalence and correlates of cannabis use in developed and developing countries","volume":"20","author":"Hall","year":"2007","journal-title":"Curr. Opin. Psychiatry"},{"issue":"7481","key":"10.1016\/j.schres.2017.04.010_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bmj.38267.664086.63","article-title":"Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people","volume":"330","author":"Henquet","year":"2005","journal-title":"BMJ"},{"issue":"4 Suppl","key":"10.1016\/j.schres.2017.04.010_bb0065","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.5694\/j.1326-5377.2009.tb02370.x","article-title":"Amphetamine psychosis: a model for studying the onset and course of psychosis","volume":"190","author":"Hermens","year":"2009","journal-title":"Med. J. Aust."},{"issue":"7570","key":"10.1016\/j.schres.2017.04.010_bb0070","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/525S14a","article-title":"Perspective: be clear about the real risks","volume":"525","author":"Hill","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.schres.2017.04.010_bb0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/10673220902724599","article-title":"Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence","volume":"17","author":"Horsfall","year":"2009","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.schres.2017.04.010_bb0080","author":"Inter-American Drug Abuse Control Commission, CICAD"},{"issue":"2","key":"10.1016\/j.schres.2017.04.010_bb0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11920-015-0657-y","article-title":"Cannabis and psychosis: a critical overview of the relationship","volume":"18","author":"Ksir","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"issue":"2\u20133","key":"10.1016\/j.schres.2017.04.010_bb0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF03033802","article-title":"What is the mechanism whereby cannabis use increases risk of psychosis?","volume":"14","author":"Luzi","year":"2008","journal-title":"Neurotox. Res."},{"issue":"5","key":"10.1016\/j.schres.2017.04.010_bb0095","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/schbul\/sbw003","article-title":"Meta-analysis of the association between the level of cannabis use and risk of psychosis","volume":"42","author":"Marconi","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"9584","key":"10.1016\/j.schres.2017.04.010_bb0100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review","volume":"370","author":"Moore","year":"2007","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.schres.2017.04.010_bb0105","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.biopsych.2016.02.005","article-title":"Cannabis and psychosis: what degree of proof do we require?","volume":"79","author":"Murray","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2017.04.010_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/wps.20341","article-title":"Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis","volume":"15","author":"Murray","year":"2016","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2017.04.010_bb0115","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.4088\/JCP.12m07822","article-title":"Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases","volume":"74","author":"Niemi-Pyntt\u00e4ri","year":"2013","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2017.04.010_bb0120","article-title":"Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light","volume":"5","author":"Paparelli","year":"2011","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.schres.2017.04.010_bb0125","first-page":"5","article-title":"Gone to pot - a review of the association between cannabis and psychosis","author":"Radhakrishnan","year":"2014","journal-title":"Front. Psych."},{"issue":"3","key":"10.1016\/j.schres.2017.04.010_bb0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.eurpsy.2011.06.012","article-title":"Risk factors for cocaine-induced psychosis in cocaine-dependent patients","volume":"28","author":"Roncero","year":"2013","journal-title":"Eur. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2017.04.010_bb0135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.schres.2013.04.017","article-title":"Differences in associations between cannabis and stimulant disorders in first admission psychosis","volume":"147","author":"Sara","year":"2013","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.schres.2017.04.010_bb0140","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1177\/0004867414533838","article-title":"Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample","volume":"48","author":"Sara","year":"2014","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.04.010_bb0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4088\/JCP.13m08878","article-title":"The impact of cannabis and stimulant disorders on diagnostic stability in psychosis","volume":"75","author":"Sara","year":"2014","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2017.04.010_bb0155","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamapsychiatry.2016.2427","article-title":"Association between continued cannabis use and risk of relapse in first-episode psychosis a quasi-experimental investigation within an observational study","volume":"73","author":"Schoeler","year":"2016","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.schres.2017.04.010_bb0165","series-title":"World Drug Report","doi-asserted-by":"crossref","DOI":"10.18356\/603a2a94-en","author":"United Nations Office on Drugs and Crime","year":"2016"},{"issue":"10","key":"10.1016\/j.schres.2017.04.010_bb0170","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1172\/JCI18533","article-title":"The addicted human brain: insights from imaging studies","volume":"111","author":"Volkow","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"7374","key":"10.1016\/j.schres.2017.04.010_bb0180","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/bmj.325.7374.1199","article-title":"Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study","volume":"325","author":"Zammit","year":"2002","journal-title":"BMJ"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417301974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417301974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T00:50:07Z","timestamp":1569027007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417301974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":31,"alternative-id":["S0920996417301974"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.04.010","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relative prevalence of schizophrenia among cannabis and cocaine users attending addiction services","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}